Skip to main navigation Skip to main content
info(at)avldigital.remove-this.de
Deutsch English
Last searches

Results for *

Displaying results 1 to 2 of 2.

  1. Experiencias internacionales sobre la concesión de licencias obligatorias por razones de salud pública
    Author: Puente, Catalina de la; Palopoli, Gastón; Silvestrini, Constanza; Correa, Juan
    Published: [2023]
    Publisher:  South Centre, Ginebra, Suiza

    The purpose of this study is to analyze the compulsory licensing (CL) regimes in selected countries, in particular the economic elements of the granting of Compulsory Licenses (CLs), the determination and negotiation of royalties to the right holder.... more

    Access:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)

    Location:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signature:
    DS 751
    Inter-library loan:
    No inter-library loan

     

    The purpose of this study is to analyze the compulsory licensing (CL) regimes in selected countries, in particular the economic elements of the granting of Compulsory Licenses (CLs), the determination and negotiation of royalties to the right holder. For this purpose, a descriptive and exploratory analysis of the experiences of granting CLs in selected countries was carried out, focusing on the experiences of developing countries considering their proximity to the Argentine case. In particular, examples of experiences of issuance of CLs or governmental use measures in developing countries are discussed. With a special focus on Latin America, where only two countries have made use of such measures for public health reasons (Ecuador and Brazil). In addition, the effectiveness of the use of CLs or governmental use measures in the reduction of prices is examined, where significant savings are evidenced. In conclusion, the paper proposes the elaboration of a methodology in relation to royalties for Argentina through a payment range that takes into consideration criteria of accessibility and affordability of the licensed technology, as well as the sustainability of the financing agents' budgets.

     
    Export to reference management software   RIS file
      BibTeX file
    Source: Union catalogues
    Language: Spanish
    Media type: Book
    Format: Online
    Other identifier:
    hdl: 10419/278410
    Series: Documento de investigación / South Centre ; 175 (22 de marzo de 2023)
    Subjects: Access to Medicines; Argentina; Compulsory Licenses; COVID-19; Doha Declaration on the TRIPS Agreement and Public Health; Flexibilities; Government Use; Health; Intellectual Property; Latin America; Pandemic; Patent; Pharmaceuticals; Public Health; TRIPS; TRIPS Agreement; TRIPS Flexibilities; WTO TRIPS Decision on COVID-19 Vaccines
    Scope: 1 Online-Ressource (circa 62 Seiten), Illustrationen
  2. The WTO TRIPS decision on COVID-19 vaccines
    what is needed to implement it?
    Author: Correa, Carlos María; Syam, Nirmalya
    Published: [2022]
    Publisher:  South Centre, Geneva, Switzerland

    The 12th WTO Ministerial Conference adopted a Ministerial Decision on the TRIPS Agreement on 17 June 2022. This partially concluded almost two years of protracted discussions in response to a proposal by India and South Africa for a waiver from... more

    Access:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)

    Location:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signature:
    DS 751
    Inter-library loan:
    No inter-library loan

     

    The 12th WTO Ministerial Conference adopted a Ministerial Decision on the TRIPS Agreement on 17 June 2022. This partially concluded almost two years of protracted discussions in response to a proposal by India and South Africa for a waiver from certain obligations under the TRIPS Agreement for health products and technologies for the prevention, treatment and containment of COVID-19. The adopted Decision only waives the obligation under article 31 (f) of the TRIPS Agreement. Developing country WTO members are now allowed to export any proportion of vaccines, including ingredients and processes, necessary for the COVID-19 pandemic that are manufactured under a compulsory license or government use authorization to other developing countries. It also contains some clarifications of relevant TRIPS provisions, while introducing a number of conditionalities that are not present in the TRIPS Agreement. This paper examines the object and scope of the Decision, the requirements established for its use, and the required actions to be taken by WTO members to implement it.

     
    Export to reference management software   RIS file
      BibTeX file
    Source: Union catalogues
    Language: English
    Media type: Book
    Format: Online
    Other identifier:
    hdl: 10419/278266
    Series: Research paper / South Centre ; 169 (8 November 2022)
    Subjects: Compulsory Licenses; COVID-19; Diagnostics; Dispute Settlement; Doha Declaration on the TRIPS Agreement and Public Health; Flexibilities; Government Use; MC12; Pandemic; Parallel Importation; Test Data; Therapeutics; TRIPS; TRIPS Agreement; TRIPS Flexibilities; TRIPS Waiver; Vaccines; Voluntary License; World Trade Organization (WTO); WTO TRIPS Decision on COVID-19 Vaccines
    Scope: 1 Online-Ressource (circa 36 Seiten)